Novo Resources is pushing ahead on multiple exploration fronts across Australia ahead of drilling at its John Bull and ...

AstraZeneca has opened a plant to produce biogas from organic waste that will ensure by the end of this year all of its ...

Drug compounders aren’t ready to give up their ability to produce off-brand versions of Novo Nordisk’s weight-loss drug ...

HIGHLIGHTS Geological and geochemical sampling campaigns designed to guide effective targeting for drill programs in Q2 2025 ...

Lars Fruergaard Jørgensen might not be a household name, but his company’s drug Ozempic is. And its success has thrust him — ...

Medicare spending on some diabetes drugs, including popular treatments such as Ozempic, surged nearly fivefold to $35.8 ...

Since, Viking's clinical data remain strong, and the company aims to launch a phase 3 trial for the injectable version of ...

Eli Lilly ( LLY) announced Wednesday that it is ramping up US manufacturing, adding four new sites to help increase the ...

The FDA recently removed semaglutide from its drug shortage list, which has not been considered commercially available since ...

Here are five things to know about the company's de novo strategy: 1. USPI added nearly 70 ASCs in 2024, remaining "very active in both [mergers and acquisitions] and de novo development." The company ...

As high prices and supply issues drive consumers to alternative markets for GLP-1s, physicians aren’t too interested in using ...

The MHRA reveals a staggering rise in deaths linked to weight loss and diabetes medications in the UK, with concerns over ...